Company intelligence / Profile preview
Bouchara Recordati
- Ownership
- Private
- Employees
- ~214
- Development stage
- Commercial
Overview
Bouchara Recordati is a French subsidiary of the global pharmaceutical group Recordati. It develops and markets both branded and generic drugs in specialty care, primary care, and rare diseases. The company has a strong commercial presence in Europe and emerging markets. Its pipeline includes both proprietary products developed in-house as well as licensed-in assets. Recent years have seen expansion into rare disease therapeutics with several products approved for orphan indications.
- Therapeutic areas
- PsychiatryCardiovascularNephrologyEndocrinologyRare DiseasesInfectious Diseases
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Bouchara Recordati.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bouchara Recordati.